MannKind Corporation
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocrinologists, and other healthcare providers for the treatment of hypothyroidism. The company has a license and collaboration agreement with United Therapeutics Corporation. It also has an agreement with NRx Pharmaceuticals to develop a dry powder formulation of ZYESAMI (aviptadil), a synthetic form of human vasoactive intestinal peptide to help protect cells against inflammatory conditions. MannKind Corporation was incorporated in 1991 and is headquartered in Westlake Village, California. Show More...
-
Website https://www.mannkindcorp.com
-
Sector Healthcare
-
Industry Biotechnology
-
Last Quote 3.69 EUR
-
Last Updated 29-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share USD -7.5 -6.6 -4.7 -3.2 -2.57 -4.54 1.36 -1.13 -0.6 -0.27 -0.23 Dividends USD Payout Ratio % * Shares Mil 23.0 24.0 36.0 60.0 77.0 81.0 92.0 104.0 144.0 196.0 202.0 Book Value Per Share * EUR -5.37 -8.24 -3.65 -1.65 -0.41 -1.33 -2.36 -1.77 -0.96 -0.78 -0.82 Free Cash Flow Per Share * EUR -5.17 -4.93 -2.77 -1.66 -0.22 -0.98 -0.95 -0.4 -0.61 -0.3 Return on Assets % -65.02 -67.45 -75.13 -75.1 -60.75 -141.48 107.65 -122.45 -90.47 -51.53 -51.16 Financial Leverage (Average) Return on Equity % Return on Invested Capital % Interest Coverage -8.82 -6.37 -6.85 -7.92 -8.7 -14.27 7.8 -7.83 -8.19 -3.76 -3.01 Current Ratio 4.08 0.23 0.46 0.6 0.5 0.29 0.84 0.65 1.09 0.93 0.72 Quick Ratio 3.92 0.13 0.43 0.55 0.42 0.22 0.58 0.53 1.0 0.81 0.64 Debt/Equity